fda bans compounded semaglutide & Tirzepatide 2025: Safe Use Guide semaglutide compounding fda news alerts

Published 2021-5-11 Type 2 diabetes mellitus (T2DM) is closely associated with cardiovascular diseases (CVD), including atherosclerosis, hypertension and heart failure

Marketplace (Affordable Care Act) plans typically dont cover weight loss drugs

The possibility of a drug that could help both metabolic and brain health is exciting, but as with all promising treatments, the whole story is more complicated

Placella exemplifies compassionate care and innovative treatment, driving lasting transformation in health and beauty

Retatrutide 40mg (Specialized Triple-Agonist Metabolic Modulator Matrix) Retatrutide 40mg Pre-filled Pen is a powerful weight management injection that contains a triple-action peptide targeting GLP-1, GIP, and glucagon receptors